Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
generactor's Profile
Displaying 351-400 of 610 result(s).
CYDY CytoDyn Inc
10/14/2020 7:15:29 AM
RLF-100/Aviptadil wasn't considered (1)
CYDY CytoDyn Inc
10/13/2020 11:20:48 AM
These are great results but Relief (3)
CYDY CytoDyn Inc
10/12/2020 1:59:17 AM
May or may not hear any news soon
CYDY CytoDyn Inc
10/11/2020 4:50:59 AM
I give it a 20% chance of being sto (3)
CYDY CytoDyn Inc
10/11/2020 4:41:10 AM
NASH would have been the best choic (5)
CYDY CytoDyn Inc
10/09/2020 7:06:05 AM
Trump's health (1)
CYDY CytoDyn Inc
10/07/2020 3:44:06 PM
Nader doesn't know the results (7)
CYDY CytoDyn Inc
10/07/2020 12:50:06 PM
Aug 25th a press release said the 1
CYDY CytoDyn Inc
10/07/2020 10:03:29 AM
I just hope Nader confirms to us th (6)
CYDY CytoDyn Inc
10/05/2020 11:56:23 AM
PR from Aug 25th announcing enrollm
CYDY CytoDyn Inc
10/02/2020 11:10:19 PM
It's been 38 days since the enrollm
CYDY CytoDyn Inc
10/02/2020 10:56:49 AM
If Trump gets any OTC traded compan (1)
CYDY CytoDyn Inc
10/01/2020 8:25:57 PM
A buyout of the Vyera contract seem (4)
CYDY CytoDyn Inc
09/30/2020 5:49:08 PM
Without covid the company would be (9)
CYDY CytoDyn Inc
09/28/2020 4:31:22 PM
The RTF may not be so cut and dried (1)
CYDY CytoDyn Inc
09/23/2020 11:30:38 AM
RLFTF/NeuroRx requested EUA from FD
CYDY CytoDyn Inc
09/23/2020 9:54:55 AM
Fife's also gets a 5% raise on the
CYDY CytoDyn Inc
09/17/2020 8:06:52 AM
The CD12 trial isn't close to being (2)
CYDY CytoDyn Inc
09/15/2020 5:03:56 PM
If the share price goes up then the (4)
CYDY CytoDyn Inc
09/15/2020 11:38:09 AM
Multi-disciplinary refers to the di (1)
CYDY CytoDyn Inc
09/14/2020 11:21:09 AM
If someone had told me a year ago w (4)
CYDY CytoDyn Inc
09/11/2020 8:09:02 AM
We don't have a PDUFA date, that's (1)
CYDY CytoDyn Inc
09/09/2020 12:08:31 PM
It's been 28 days since the topline
CYDY CytoDyn Inc
09/09/2020 10:49:23 AM
The longer we go without a phase 3 (8)
CYDY CytoDyn Inc
09/04/2020 6:40:41 PM
We would actually have more than 90
CYDY CytoDyn Inc
09/04/2020 5:13:32 PM
It's a desperate move to keep HGEN' (1)
CYDY CytoDyn Inc
09/03/2020 2:39:38 AM
I imagine it would be a quick appro
CYDY CytoDyn Inc
08/30/2020 7:52:08 PM
It's likely just an issue of coding (1)
CYDY CytoDyn Inc
08/28/2020 5:14:11 PM
So we know we aren't getting an EUA
CYDY CytoDyn Inc
08/27/2020 3:07:34 PM
NASDAQ obviously has to approve the
CYDY CytoDyn Inc
08/27/2020 3:01:09 PM
The continuing lack of a phase 3 an (3)
CYDY CytoDyn Inc
08/25/2020 6:22:53 PM
I think the silence probably means (1)
CYDY CytoDyn Inc
08/25/2020 5:28:34 PM
My guess is that there is a back-an
CYDY CytoDyn Inc
08/21/2020 8:12:01 PM
RLF-100 being an effective therapeu (2)
CYDY CytoDyn Inc
08/21/2020 7:46:09 PM
The risk is significant because if (3)
CYDY CytoDyn Inc
08/20/2020 3:25:34 PM
These pictures made me laugh (3)
CYDY CytoDyn Inc
08/19/2020 6:52:35 PM
How many patients are in the sub gr
CYDY CytoDyn Inc
08/19/2020 3:41:21 PM
Given the speed in which the data w (1)
CYDY CytoDyn Inc
08/19/2020 3:14:51 PM
Looking at those case studies of dr
CYDY CytoDyn Inc
08/19/2020 2:57:30 PM
I agree. The reason RLFTF looks pro (1)
CYDY CytoDyn Inc
08/19/2020 2:29:41 PM
I just think investors are over Cov (1)
CYDY CytoDyn Inc
08/17/2020 1:26:04 PM
Mod says now that the poster is try (2)
CYDY CytoDyn Inc
08/12/2020 5:11:34 PM
I thought BP was singing Leronlimab (1)
CYDY CytoDyn Inc
08/12/2020 4:43:18 PM
Not buying that Nader is not involv (6)
CYDY CytoDyn Inc
08/12/2020 12:59:25 PM
I was very skeptical of getting an (1)
CYDY CytoDyn Inc
08/12/2020 12:48:24 PM
Nader attracts shorts like moths to (2)
CYDY CytoDyn Inc
08/11/2020 12:12:29 PM
Will Nader push to unblind the seve
CYDY CytoDyn Inc
08/11/2020 10:45:26 AM
Dr Yo is convinced (7)
CYDY CytoDyn Inc
08/11/2020 10:08:41 AM
Just got an email back from Nader, (4)
CYDY CytoDyn Inc
08/11/2020 10:05:58 AM
I agree it is an error and sent Nad
Go to page:
  • << First
  • < Previous
  • 7
  • 8
  • Next >

Recent Articles

  • Cinemark Achieves Record Growth in Food and Beverage Sales
  • Kazia Therapeutics Secures $2 Million Fundraising Initiative
  • Grainger Achieves Strong Financial Performance in Q2
  • European Wax Center Introduces First Full-Body Deodorant
  • Oppenheimer Holdings Inc. Announces Q2 2025 Financial Gains
  • Celebrate SpongeBob SquarePants with Postal Service Stamps
  • Innovative Device Transforms Relief for Hand Swelling
  • JAS Welcomes New Leadership to Support Global Ambitions
  • Unlock Unlimited Check Printing with ezCheckPrinting Today
  • Alkami Leadership to Make Key Presentation at Technology Forum
  • Major Sale Events Announced as At Home Closes Six Stores
  • Demetra Strengthens Position with Acquisition of OrthoFundamentals
  • Jericho Project Earns Funding for Veterans Housing Support
  • NEXGEL Secures $950,000 in Direct Offering for Growth
  • HashJ's New ETH Contract Model Revolutionizes Market Access
  • Abeona Therapeutics Awards Employee Equity Grants to Boost Growth
  • Upcoming Financial Results Call for Knight Therapeutics Inc.
  • Orchestra BioMed Successfully Launches $40 Million Stock Offering
  • Trump's Challenge to Federal Reserve Leadership Faces Skepticism
  • Amazon Weathers Storm: CEO Addresses Capacity Concerns Directly
  • Abercrombie & Fitch Co. Earnings Call Scheduled for Late August
  • NCC Group PLC: Insights on Securities Disclosure and Position
  • Kayne Anderson Energy Fund Announces New Monthly Distribution Rate
  • Understanding Recent Investigations for Key Corporations
  • Transformative Partnership Between FOXO and Covenant Health
  • Investment Highlights from CNBC's Final Trades on Key Stocks
  • Spectral Capital's Hybrid Innovations Revolutionize AI Efficiency
  • InPlay Oil Corp. Announces Dividend and Future Opportunities
  • Curaleaf Launches New Dispensary in St. Augustine, Florida
  • Aegis Brands Sees Resilience With New Store Performance
  • IES Holdings Achieves Growth and Expansion in Q3 Results
  • Curaleaf Launches New Dispensary, Enhancing Patient Access
  • Bybit Launches Exciting Credit Incentive for TradFi Users
  • Impact of Trade Policy Shifts on Global Markets and Tariffs
  • Emergence of a New Global Economy Amid Tariff Changes
  • Amazon's Stock Struggles Despite Impressive Earnings Report
  • IES Holdings Achieves Strong Growth in Q3 Fiscal 2025 Results
  • Artelo Biosciences' ART12.11 Gains Momentum with UK Feedback
  • Abeona Therapeutics Offers New Equity Grants to Employees
  • NeuroPace Celebrates Critical Reimbursement Decision Impacting Epilepsy Care
  • Knight Therapeutics Plans Conference Call for Q2 2025 Results
  • Intellia Therapeutics Expands Team with New Stock Awards
  • Aptose's New Auditor Ernst & Young Strengthens Financial Future
  • Nexxen's Recent Share Buyback Program In-Depth Overview
  • InterRent REIT's All-Cash Deal: A Clear Opportunity for Unitholders
  • Spectral Capital Innovates Over 100 Hybrid Technologies for AI
  • Berkshire Hills Bancorp Declares Dividend for Shareholders
  • Cboe Global Markets' Profits Surge: Key Insights from Q2 Results
  • Celebrate 85 Years of Sturgis with 2LaneLife's Epic Journey
  • Astute Connect's Expert Network Market Projected Growth Surge
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site